Stock screener
All disclosures →
EDGAR →
CYTK
Conviction 58HealthcareScan · Mon, Aug 10, 2026CYTK$77.51+0.98%
ResistanceSupportVol 14Insider sellCongress buyCongress sell3
Vol MA14 2.08M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price77.51
Change+0.98%
Gap-0.74%
Rel volume1.64×
Avg volume1.88M
Avg $ vol149.33M
SMA 2079.79
SMA 5078.69
SMA 20068.49
Price vs 50-1.50%
Price vs 200+13.17%
MA stackmixed
50/200 cross—
Supertrenddown · 84.64
RSI (14)45
MACD hist-0.40
MACD cross—
Stoch %K / %D29 / 41
ADX (14)14
+DI / −DI18 / 20
RSI divergence—
MACD divergenceBullish
ATR %+3.96%
ADR %3.74%
52w high87.26
52w low33.23
From 52w high-11.17%
Above 52w low+133.25%
New 52w highNo
SqueezeOn · 3d
Bollinger width9.18%
%B0.19
Donchian pos29.31%
Donchian high83.83
Donchian low74.89
AVWAP (52w high)81.45
vs AVWAP high-4.84%
AVWAP (52w low)64.90
vs AVWAP low+19.43%
OBV trendFlat
Chaikin MF (20)-0.04
Today vs 20d1.64×
Avg vol (14d)2.08M
Avg vol (20d)1.88M
Avg $ vol (20d)149.33M
Market cap10.78B
RS 3m (vs SPY)-2.37%
RS 6m (vs SPY)+13.31%
RS line new highNo
Trend template6/8
Technical rank57.1
1 week+1.39%
1 month-8.67%
3 months+0.78%
6 months+24.33%
1 year+119.89%
YTD+25.56%
P/E-13.73
P/B-62.11
P/S122.40
P/FCF-20.15
EPS-6.54
Div yield—
ROE452.46%
ROA-40.79%
Debt/Eq-1.59
Current6.66
EV/EBITDA-17.93
Gross margin—
Net margin-891.60%
Rev growth376.56%
EPS growth-33.15%
Price target110.86
Target upside43.03%
Analyst ratingBuy
Institutional118.76%
Ent. value10.8B
Revenue28.62M
Net income-198.76M
Gross profit—
Free cash flow-534.82M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out124.43M
Employees673
ListedThu, Apr 29, 2004
Free float120.88M
Float %97.3%
Short interest17.05M
Days to cover9.0d
Short volume57.9%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.50 vs −$1.63
Last surprise+8.0% beat
Setup gradeC
Conviction58 / 100
Pattern quality—
Tech rank57.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance88.12
Support76.58
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CYTK · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · D · CA · traded 2026-06-30 | Buy | $1K–$15K | 2026-06-30 | 2026-07-02 | |
Gilbert Cisneros house · CA · traded 2025-10-09 | Buy | $1K–$15K | 2025-10-09 | 2025-11-12 | |
Lisa McClain house · R · MI · traded 2025-06-17 | Sell | $1K–$15K | 2025-06-17 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-11 | Buy | $1K–$15K | 2025-06-11 | 2025-08-13 |
Insider activity
SEC Form 4 transactions in CYTK · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Blum Robert I President & CEO · Common Stock · 2026-07-27 | Exercise | 7.5K | $80K | 2026-07-27 | 2026-07-27 |
Blum Robert I President & CEO · Common Stock · 2026-07-27 | Sell | 7.5K | $607K | 2026-07-27 | 2026-07-27 |
Blum Robert I President & CEO · Non-Qualified Stock Option (Right to Buy) · 2026-07-27 | Exercise | 7.5K | — | 2026-07-27 | 2026-07-27 |
Daly James M Director · Common Stock · 2026-07-15 | Grant | 151 | $12K | 2026-07-15 | 2026-07-16 |
Harrington Robert Arthur Director · Common Stock · 2026-07-15 | Grant | 151 | $12K | 2026-07-15 | 2026-07-16 |
HENDERSON JOHN T Director · Common Stock · 2026-07-15 | Grant | 272 | $22K | 2026-07-15 | 2026-07-16 |
Kaye Edward M. MD Director · Common Stock · 2026-07-15 | Grant | 151 | $12K | 2026-07-15 | 2026-07-16 |
WIERENGA WENDELL Director · Common Stock · 2026-07-15 | Grant | 75 | $6K | 2026-07-15 | 2026-07-16 |
Wysenski Nancy Director · Common Stock · 2026-07-15 | Grant | 75 | $6K | 2026-07-15 | 2026-07-16 |
Malik Fady Ibraham EVP Research & Development · Common Stock · 2026-07-07 | Exercise | 3.5K | $27K | 2026-07-07 | 2026-07-07 |
SEC filings
EDGAR filings in CYTK · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.